Clinical Trial Update: TH9507 in Patients With HIV-Associated Lipodystrophy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating TH9507 for HIV-associated lipodystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Lipodystrophy

Drugs mentioned

• TH9507

Snippet

Sponsor: Theratechnologies | Conditions: HIV Infections, Lipodystrophy | Phase 3 | Status: COMPLETED